ArticleJournal of inflammation research2025
Ferroptosis-Related Gene CRYAB in Asthma: Bioinformatics Identification and Experimental Validation.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, has been implicated in the pathogenesis of asthma. This study aimed to identify and validate ferroptosis-related genes (FRGs) associated with asthma through bioinformatics analysis, clinical samples, and experimental validation, thus providing new insights for treatment. Methods: Transcriptome data from induced sputum samples of asthma patients were obtained from the GEO database. Differentially expressed genes (DEGs) were subjected to GO and KEGG enrichment analyses. In addition, LASSO and SVM-RFE algorithms were employed to screen FRGs related to asthma. The expression levels and predictive efficacy of the signature genes were verified by differential expression analysis and ROC curves, and ssGSEA was used to further analyze their relationship with immune cell infiltration levels. Lung tissue samples from clinical cases were collected to validate gene expression in vivo. Additionally, BEAS-2B cells were selected for in vitro experiments, and small interfering RNA silencing and pcDNA3.1 overexpression candidate genes were used to further validate their role in ferroptosis. Results: The FRGs TFRC and CRYAB were identified as differentially expressed in asthma. Immune infiltration analysis revealed significant alterations in immune cell abundance that correlated with signature gene expression levels in asthmatic samples. However, only CRYAB was significantly upregulated in lung tissues from asthmatic patients compared to controls. In vitro experiments demonstrated that erastin-induced ferroptosis led to downregulation of CRYAB expression in BEAS-2B cells; conversely, overexpression of CRYAB resulted in decreased MDA and ROS levels but increased GSH content, thereby protecting BEAS-2B cells against ferroptosis. Conclusion: This study is the first to highlight the pivotal role of CRYAB among FRGs in asthma pathogenesis. Notably, overexpression of CRYAB inhibits ferroptosis-suggesting its potential as a valuable biomarker for personalized diagnosis and therapy for asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.